. >> we're faced with global threat of infectious diseases from the pneumonias, tb, malar malaria, and other killers that are killing the world's children and people. so what we need is political will. there is no money in the drug for malaria and tb, really, and they are based--the problems are faced by the world. the sanitation, the vaccines, to look at these things that help us fate th face the threats. >> cacan pharmaceuticals still make a profit? >> yes, we're bringing in partners together to open the dialogue on how to on one hand to stimulate the development of new drugs. but on the other hand look at anti-antibiotics not as commercial goods but public goods. so reimbursement to the expenditures in the development of new drugs should not b be--shoul--so once developed the new drugs we have to preserve them. but this is not the only measure that will surface in tackling new drugs. if we do not take care of better practice in prescribing only using and prevention just having new drugs will not solve the problem. because you see again the emergence of anti-microbial resistence, and